Dr. Manuela Prokesch will lead the Neuropharmacology department of QPS Austria GmbH from January 1, 2022. QPS Holdings LLC announced that Dr. Prokesch, currently…
Newark, Delaware, July 30, 2021 – QPS, a global contract research organization (CRO) focused on bioanalytics and clinical trials, is honored to have collaborated…
Newark, Delaware, June 2, 2021 – QPS, a GLP/GCP-compliant and CLIA-certified contract research organization (CRO) delivering discovery, preclinical, and clinical drug development services since…
Clinical Research Studies Support Economic Growth and Development During A Pandemic, While Making a Global Difference Springfield, Missouri; November 12, 2020 – QPS announced…
QPS is a GLP/GCP-compliant and CLIA-certified contract research organization (CRO) delivering discovery, preclinical, and clinical drug development services since 1995. An award-winning leader focused…
QPS, a global contract research organization (CRO) that provides discovery, preclinical, and clinical drug development services, is reinforcing its focus on qualitative and quantitative…
QPS, a global contract research organization (CRO) that provides GLP-compliant discovery, preclinical, and clinical drug development services, announced a newly developed capability to conduct…
As drug companies race to find treatments and vaccines to combat the novel coronavirus, QPS, a global contract research organization (CRO) providing discovery, preclinical…
Since September 19, 2016, QPS has closely collaborated with G-CURE, a cardiovascular research organization originating from and closely linked to the Department of Cardiology at…
Newark, Delaware, September 18, 2019 – QPS, a leading contract research organization (CRO), continues to expand its global footprint with new clinics in the Netherlands and…